| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 3, Issue 11 791-802, Copyright © 1992 by American Association of Cancer Research
ARTICLES |
RA Blanton, MD Coltrera, AM Gown, CL Halbert and JK McDougall
Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Monolayer cultures of human foreskin and ectocervical epithelial cells were infected with retroviral vectors expressing HPV16 oncogenes, selected for G418 resistance, and cultured organotypically so that they reformed the fully differentiated, stratified squamous tissues from which they were originally derived. Expression of HPV16 E7 prevented cell cycle withdrawal in the suprabasal layers of these stratified cultures but had no effect on terminal differentiation. Cultures expressing E7 alone and those coexpressing E6 and E7 were identical in terms of suprabasal proliferation and terminal differentiation, but they differed in expression of the endogenous tumor suppressor protein p53. Immunohistochemically detectable p53 protein localized to the proliferative compartment in normal and E7-containing cultures but was undetectable in those cultures which coexpressed E6 and E7. This result suggests that E7-induced suprabasal proliferation is independent of the steady-state level of p53.
This article has been cited by other articles:
![]() |
A.-M. Helt, J. O. Funk, and D. A. Galloway Inactivation of both the Retinoblastoma Tumor Suppressor and p21 by the Human Papillomavirus Type 16 E7 Oncoprotein Is Necessary To Inhibit Cell Cycle Arrest in Human Epithelial Cells J. Virol., September 11, 2002; 76(20): 10559 - 10568. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Helt and D. A. Galloway Destabilization of the Retinoblastoma Tumor Suppressor by Human Papillomavirus Type 16 E7 Is Not Sufficient To Overcome Cell Cycle Arrest in Human Keratinocytes J. Virol., August 1, 2001; 75(15): 6737 - 6747. [Abstract] [Full Text] |
||||
![]() |
L. G. Martin, G. W. Demers, and D. A. Galloway Disruption of the G1/S Transition in Human Papillomavirus Type 16 E7-Expressing Human Cells Is Associated with Altered Regulation of Cyclin E J. Virol., February 1, 1998; 72(2): 975 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. M. Steenbergen, J. N. Parker, S. Isern, P. J. F. Snijders, J. M. M. Walboomers, C. J. L. M. Meijer, T. R. Broker, and L. T. Chow Viral E6-E7 Transcription in the Basal Layer of Organotypic Cultures without Apparent p21cip1 Protein Precedes Immortalization of Human Papillomavirus Type 16- and 18-Transfected Human Keratinocytes J. Virol., January 1, 1998; 72(1): 749 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Jones, R. M. Alani, and K. Munger The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2 Genes & Dev., August 15, 1997; 11(16): 2101 - 2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Cheng, D C Schmidt-Grimminger, T Murant, T R Broker, and L T Chow Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes & Dev., October 1, 1995; 9(19): 2335 - 2349. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |